Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $21.4300 (0.19%) ($20.3600 - $21.6700) on Sun. Jun. 23, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.14% (three month average) | RSI | 32 | Latest Price | $21.4300(0.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.4% a day on average for past five trading days. | Weekly Trend | ATRA declines -2.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting ATRA price | ATRA will decline at least -2.07% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.07% (StdDev 4.14%) | Hourly BBV | 0 () | Intraday Trend | 0.8% | | | |
|
1 - 5 Day Possible Target | $15.73(-26.6%) | Resistance Level | $22.38 | 5 Day Moving Average | $21.73(-1.38%) | 10 Day Moving Average | $21.89(-2.1%) | 20 Day Moving Average | $22.38(-4.24%) | To recent high | -47.8% | To recent low | 0.2% | Market Cap | $N/A | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |